HMGB3 cooperates with SOX9 to induce NANOG transactivation, promote the expression of oncogenic genes downstream of NANOG, and further enhance prostate adenocarcinoma cell survival and migration [36]. Here, SOX9 is linked to prostate adenocarcinoma.